VANTEDGE MEDICAL APPOINTS GREGORY SANTORNO AS CHIEF COMMERCIAL OFFICER

Proven and dynamic commercial leader in MedTech with more than two decades of driving business growth and enabling unparalleled customer satisfaction

San Jose, Calif. (June 17, 2024) – Vantedge Medical (“Vantedge”), proven partner to medical device OEM customers in complex precision machining, sophisticated sheet metal manufacturing and assembly and portfolio company of Aterian Investment Partners (“Aterian”), has appointed Gregory Santorno as Chief Commercial Officer (“CCO”). 

With over two decades in the medical device manufacturing industry, Greg has showcased remarkable accomplishments in enhancing business growth and ensuring customer satisfaction. Most recently as Global Vice President of Sales at Biocoat Incorporated, he played a pivotal role in driving business expansion and leading market initiatives. Greg's outstanding leadership skills were evident in crafting strategic growth plans, optimizing resources in key MedTech markets in California and Minnesota, and introducing innovative sales tactics to target key clients, positioning the company for accelerated growth. Prior to Biocoat, Greg served as the Vice President of Global Accounts at Viant Medical. In this position, he oversaw global account management teams in North America, Europe, and Asia, spanning 25 sites worldwide, leading to the acquisition of approximately $100 million in new business. Under his leadership, his team efficiently managed a revenue base exceeding $700 million, ultimately contributing to the company's total revenue surpassing $1 billion. Greg holds a Bachelor of Science in Industrial Technology Management from Colorado State University.

Brian King, Chairman & CEO of Vantedge Medical said, “Greg brings a wealth of experience and a proven track record of driving commercial success and fostering organizational growth in the medical device manufacturing industry. I have worked directly with Greg before and am confident that his expertise will bring significant value to Vantedge Medical. He is uniquely qualified to lead our commercial organization.”

“I am both honored and thrilled to join Vantedge Medical, a company known for passionate customer collaboration, facilitation of innovation, and accelerating time to market. As CCO, I am committed to our commercial success through serving our associates across the company, and to help deliver our mission and vision of partnering with our customers to make a difference in the lives of patients and their families, as the premier metals-based med-tech solutions partner.”, commented Greg Santorno, CCO.

About Vantedge Medical

Vantedge Medical is the premier metals-based med-tech solutions partner from concept to full-scale manufacturing. At the forefront of precision engineering and innovation, the Vantedge team specializes in the development and manufacturing of vital components and capital equipment for medical markets such as Robotic Assisted Surgery, Orthopedics, Surgical Instruments, Dental, and more. The organization’s teams work in unison, collaborating and problem-solving at eight sites across the United States, certified to ISO 9001 and 13485 with FDA registration to serve the manufacturing needs of the top Medical Original Equipment Manufacturers (OEMs) around the globe.

For more information, please visit http://www.vantedgemedical.com

About Aterian Investment Partners

Aterian Investment Partners is a private equity firm that invests in industry-leading, middle market businesses. In collaboration with management, Aterian holistically supports organizations with a focus on strategic positioning, people, processes, equipment, technology, and product innovation among others. With offices in New York and Florida, Aterian has raised cumulative equity commitments of more than $2 billion since its founding in 2009. 

For more information, please visit http://www.aterianpartners.com